Super Vilitra
$ 52,00 – $ 159,00Price range: $ 52,00 through $ 159,00
Tadagra Strong
$ 38,00 – $ 58,00Price range: $ 38,00 through $ 58,00
Tadagra
$ 11,00 – $ 90,00Price range: $ 11,00 through $ 90,00
Tadagra is a powerful and reliable medication specifically formulated to address the symptoms of erectile dysfunction in men. By utilizing the active ingredient Tadalafil, it works to enhance blood flow and support the natural physical response necessary for intimacy. One of the most notable features of this treatment is its long-lasting effect, which can remain active in the body for up to 36 hours. This extended window of efficacy allows for greater spontaneity and helps restore confidence in personal relationships. Available in several convenient dosages, Tadagra provides an effective solution for maintaining a healthy and fulfilling lifestyle.
Active substance: Tadalafil
SKU:
Tadagra
Categories: Blood Pressure, Erectile Dysfunction
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Tadagra belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, containing the active substance tadalafil. It is a prescription-only oral therapy indicated primarily for the treatment of erectile dysfunction (ED) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in adult males.
In the United States, tadalafil formulations are regulated by the Food and Drug Administration (FDA) and are dispensed in accordance with applicable federal and state regulations upon presentation of a valid prescription. Clinical evaluation by a licensed healthcare provider is required to determine appropriate dosing, assess cardiovascular risk, and exclude potential drug interactions before initiating treatment.
| Parameter | Clinical Detail |
|---|---|
| Active Ingredient (INN) | Tadalafil |
| Therapeutic Class | Phosphodiesterase Type 5 (PDE5) Inhibitor |
| Primary Indications | Erectile Dysfunction, Benign Prostatic Hyperplasia |
| Route of Administration | Oral |
| Prescription Status | Prescription Only (Rx) |
| Storage Conditions | 15°C to 30°C (59°F to 86°F) |
Pharmacological Profile and Clinical Indications
How the drug works (Mechanism of Action)
Tadagra exerts its therapeutic effect through the selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During physiological sexual arousal, nitric oxide is locally released in the corpus cavernosum of the penis. Nitric oxide activates the enzyme guanylate cyclase, leading to increased levels of cGMP. Elevated cGMP induces smooth muscle relaxation and enhanced blood flow into the cavernous tissues, resulting in an erection. By inhibiting the PDE5 enzyme responsible for cGMP degradation, tadalafil preserves cGMP levels. It is important to note that sexual stimulation is necessary for tadalafil to produce an effect in erectile dysfunction. In the treatment of benign prostatic hyperplasia, PDE5 inhibition decreases smooth muscle tone in the prostate and bladder neck, reducing lower urinary tract symptoms.
Therapeutic Indications and Dosing
Main uses (Indications)
Tadagra is indicated for the treatment of erectile dysfunction in adult men, the treatment of the signs and symptoms of benign prostatic hyperplasia, and the combined treatment of ED and BPH occurring concurrently. While its primary FDA-approved indications are restricted to these urological conditions, PDE5 inhibitors including tadalafil have been evaluated in medical literature for off-label management of secondary Raynaud’s phenomenon; however, off-label use must be evaluated and supervised exclusively by a qualified healthcare provider based on patient-specific clinical criteria.
Dosing schedule (Dosage and Administration)
Tadagra is available in oral tablet forms of varying strengths, typically including 2.5 mg, 5 mg, 10 mg, and 20 mg. Dosing regimens depend on the targeted indication and clinical response. For on-demand use in erectile dysfunction, the recommended starting dose is generally 10 mg taken prior to anticipated sexual activity, which may be adjusted to 20 mg or reduced to 5 mg based on individual efficacy and tolerability. For once-daily administration in ED or BPH, doses of 2.5 mg or 5 mg are taken at approximately the same time each day without regard to the timing of sexual activity. Dosage adjustments are necessary for patients with moderate to severe renal impairment or hepatic impairment as determined by a prescribing physician.
Pharmacokinetics and Safety Profile
What happens in the body (Pharmacokinetics)
Following oral administration, tadalafil is rapidly absorbed. Maximum observed plasma concentrations (Cmax) are reached between 30 minutes and 6 hours, with a median time (Tmax) of 2 hours post-dose. Absolute bioavailability has not been fully established, but absorption rate and extent are not meaningfully affected by food intake. Tadalafil is widely distributed into body tissues and is approximately 94% bound to plasma proteins. Metabolism occurs extensively in the liver, primarily via the cytochrome P450 3A4 (CYP3A4) isoenzyme pathway, converting the compound to an inactive catechol metabolite. Tadalafil exhibits a mean terminal elimination half-life of approximately 17.5 hours in healthy individuals, permitting sustained therapeutic plasma levels over an extended duration. Clearance occurs predominantly as inactive metabolites via feces (approximately 61%) and urine (approximately 36%).
Adverse reactions (Side Effects)
Clinical evaluations demonstrate that most adverse events associated with tadalafil are mild to moderate in severity and transient in nature. The most commonly reported side effects include headache, dyspepsia (indigestion), back pain, myalgia (muscle aches), nasal congestion, facial flushing, and pain in the extremities. Back pain and myalgia typically occur 12 to 24 hours post-dose and resolve within 48 hours. Less common but serious adverse events require immediate emergency medical evaluation, including priapism (a prolonged erection lasting longer than 4 hours), sudden decrease or loss of vision attributed to non-arteritic anterior ischemic optic neuropathy (NAION), and sudden decrease or loss of hearing, occasionally accompanied by tinnitus or dizziness.
Compatibility with other medicines (Drug Interactions)
Concomitant administration of Tadagra with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) in any form, or nitric oxide donors (such as amyl nitrite), is strictly contraindicated due to the risk of severe, potentially life-threatening hypotension. Co-administration with guanylate cyclase stimulators, such as riociguat, is also contraindicated. Caution is warranted when co-administering PDE5 inhibitors with alpha-blockers (e.g., tamsulosin, doxazosin) or antihypertensive medications, as additive blood pressure lowering may precipitate symptomatic hypotension or orthostatic syncope. Co-administration of potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin) significantly increases tadalafil systemic exposure, requiring dose reductions, whereas CYP3A4 inducers (e.g., rifampin, carbamazepine) decrease plasma concentrations, potentially reducing therapeutic efficacy.
Precautions and Special Considerations
What to avoid while taking it (Food and Alcohol)
Tadagra may be taken with or without food, as food does not clinically alter the rate or extent of tadalafil absorption. However, consumption of grapefruit or grapefruit juice should be avoided or limited, as grapefruit components inhibit CYP3A4 metabolism and can elevate plasma concentrations of tadalafil, increasing the likelihood of adverse effects. Concomitant use of alcohol and tadalafil requires caution; heavy alcohol consumption (e.g., 5 units or more) combined with tadalafil increases the potential for orthostatic signs and symptoms, including increased heart rate, standing blood pressure decrease, dizziness, and headache.
Important precautions (Warnings and Special Populations)
Prior to initiating therapy, healthcare providers must conduct a full cardiovascular assessment, as sexual activity carries a degree of cardiac risk in patients with pre-existing cardiovascular disease. Tadagra is not recommended for patients with recent myocardial infarction (within 90 days), unstable angina, severe heart failure, uncontrolled arrhythmias, severe hypotension, or uncontrolled hypertension. In special populations, such as elderly patients (65 years of age or older), specific dose adjustments based solely on age are generally not required, but lower starting doses may be indicated due to decreased renal or hepatic function. Tadagra is not indicated for use in pediatric populations or female patients.
If you skip a dose (What to do if you miss a dose)
For patients prescribed a once-daily dosing regimen for BPH or daily ED therapy, a missed dose should be taken as soon as it is remembered on the same day. If the missed dose is not remembered until the following day, the patient should skip the missed dose and resume the regular daily schedule. Patients should never double the dose or take extra tablets to make up for a missed dose. For patients utilizing an on-demand dosing schedule prior to sexual activity, missed dose protocol does not apply, as the medication is taken only when needed, not exceeding one dose per 24-hour period.
Storage and expiration (Storage and Expiry)
Tadagra tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with short excursions permitted between 15°C and 30°C (59°F to 86°F) in accordance with standard USP guidelines. The medication must be kept in its original packaging to protect the contents from moisture, direct light, and excessive heat. Keep out of reach of children and domestic animals. Expired or unused medication should be disposed of in accordance with local environmental and pharmaceutical waste regulations or returned through authorized drug take-back programs.
Common Questions
How does food intake affect the absorption of Tadagra?
Clinical pharmacokinetic studies indicate that the absorption rate and overall extent of systemic exposure to tadalafil are not significantly altered by food. Consequently, Tadagra may be administered independently of meal times. However, excessive consumption of grapefruit products should be avoided due to potential CYP3A4 metabolic inhibition.
What immediate steps should be taken if an erection lasts longer than four hours?
An erection persisting longer than 4 hours is defined medically as priapism, a urological emergency. If an erection lasts longer than 4 hours, immediate emergency medical attention must be sought. Delay in seeking prompt treatment can lead to permanent structural damage to penile tissue and irreversible loss of erectile function.
Can Tadagra be taken concurrently with blood pressure lowering medications?
Caution is required when combining Tadagra with antihypertensive drugs or alpha-blockers. Because both PDE5 inhibitors and blood pressure medications exert vasodilatory effects, co-administration can cause additive reductions in blood pressure, leading to symptoms such as dizziness, lightheadedness, or fainting. A healthcare provider must evaluate all current cardiovascular medications before prescribing tadalafil.
Why is the 17.5-hour half-life of tadalafil clinically significant?
The mean terminal elimination half-life of 17.5 hours is notably longer than that of other available PDE5 inhibitors. This prolonged half-life maintains therapeutic plasma concentrations over an extended window (up to 36 hours for on-demand dosing), allowing for flexible timing without requiring repeated dosing within a short timeframe.
Is dose adjustment required for individuals with decreased renal function?
Yes, renal clearance of tadalafil metabolites decreases in patients with renal impairment. For patients with moderate renal impairment (creatinine clearance 30 to 50 mL/min), a lower starting dose is recommended. For patients with severe renal impairment or those undergoing hemodialysis, the maximum recommended dose is reduced, and once-daily regimens are generally not recommended due to increased systemic exposure.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
20 mg |
|---|---|
| Package |
10 pills ,20 pills ,30 pills ,60 pills ,90 pills ,120 pills ,180 pills ,270 pills |
| Ενεργός Ουσία |
Related products
Aldactone
$ 33,00 – $ 345,00Price range: $ 33,00 through $ 345,00
Active substance: Spironolactone
More Details
This product has multiple variants. The options may be chosen on the product page
Benicar
$ 42,00 – $ 478,00Price range: $ 42,00 through $ 478,00
Active substance: Olmesartan
More Details
This product has multiple variants. The options may be chosen on the product page
Betapace
$ 9,00 – $ 260,00Price range: $ 9,00 through $ 260,00
Active substance: Sotalol
More Details
This product has multiple variants. The options may be chosen on the product page
Capoten
$ 42,00 – $ 323,00Price range: $ 42,00 through $ 323,00
Active substance: Captopril
More Details
This product has multiple variants. The options may be chosen on the product page
Cozaar
$ 41,00 – $ 281,00Price range: $ 41,00 through $ 281,00
Active substance: Losartan
More Details
This product has multiple variants. The options may be chosen on the product page
Diltiazem
$ 49,00 – $ 590,00Price range: $ 49,00 through $ 590,00
Active substance: Diltiazem
More Details
This product has multiple variants. The options may be chosen on the product page
Diltiazem HCL
$ 52,00 – $ 393,00Price range: $ 52,00 through $ 393,00
Active substance: Diltiazem
More Details
This product has multiple variants. The options may be chosen on the product page
Ecosprin
$ 19,00 – $ 57,00Price range: $ 19,00 through $ 57,00
Active substance: aspirin
More Details
This product has multiple variants. The options may be chosen on the product page
